SCHEMBL4602833

SCHEMBL4602833

COc1ccc(-c2cc(C(=O)O)c3cc(C)cc(C)c3n2)cc1F

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.52
MAPT P10636 5/20 0.52
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
ALDH1A1 P00352 3/20 0.52
POLB P06746 2/20 0.52
TDP1 Q9NUW8 2/20 0.52
GAA P10253 1/20 0.52
PKM P14618 1/20 0.52
APEX1 P27695 1/20 0.52
RCE1 Q9Y256 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
EPRS1 P07814 2/20 0.49
PDE10A Q9Y233 1/20 0.49
DHODH Q02127 3/20 0.46
SMN1; SMN2 Q16637 3/20 0.45
HSD17B10 Q99714 1/20 0.45
LMNA P02545 3/20 0.45
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4602311 0.84 KDM4E (0.62) KDM4EMAPTMEN1KMT2AALDH1A1
SCHEMBL117228 0.80 EPRS1 (0.65) KDM4EMAPTMEN1KMT2AALDH1A1
SCHEMBL28576456 0.79 DHODH (0.69) KDM4EMAPTMEN1KMT2AALDH1A1
SCHEMBL4601004 0.77 KDM4E (0.67) KDM4EMAPTMEN1KMT2AALDH1A1
SCHEMBL4601628 0.76 KDM4E (0.56) KDM4EMAPTMEN1KMT2AALDH1A1
SCHEMBL4603041 0.76 EPRS1 (0.63) KDM4EMAPTMEN1KMT2AALDH1A1
SCHEMBL3578606 0.76 KMT2A (0.65) KDM4EMAPTMEN1KMT2AALDH1A1
SCHEMBL6893834 0.76 KDM4E (0.53) KDM4EMAPTMEN1KMT2APOLB
SCHEMBL14557586 0.74 MAPT (0.45) KDM4EMAPTMEN1KMT2AALDH1A1
SCHEMBL4601899 0.73 DHODH (0.61) KDM4EMAPTMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1912970-A2 ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL Bayer Schering Pharma Aktiengesellschaft (DE) 2008-04-23 EP claimed
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US claimed
WO-2007017289-A2 ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-02-15 WO claimed
EP-1912970-A2 ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL Bayer Schering Pharma Aktiengesellschaft (DE) 2008-04-23 EP disclosed
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US disclosed
WO-2007017289-A2 ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-02-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060573-A1 Acyltryptophanols FSHR, NPY1R, NPY2R KDM4E 2399/4885MAPT 4047/4885MEN1 410/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.